Published October 24, 2025 | Version v1

INSON ORGANIZMIDA PATOGEN ZAMBURUGʻLAR: BIOLOGIK XUSUSIYATLAR, KASALLIK KELTIRISH MEXANIZMLARI VA DAVOLASH YONDASHUVLARI

  • 1. Qo'qon Universiteti Andijon filiali Mikrobiologiya, virusologiya va immunologiya kafedrasi

Description

Ushbu maqolada inson organizmida uchraydigan asosiy patogen zamburugʻlar, ularning biologik xususiyatlari, kasallik keltirish mexanizmlari hamda davolash yondashuvlari yoritiladi. Candida, Aspergillus, Cryptococcus va Pneumocystis kabi turlar eng muhim patogenlar qatoriga kiradi. Ularning patogenligi ko‘pincha immunitetning zaiflashuvi bilan bogʻliq bo‘lib, diagnostika va davolash usullari murakkablik kasb etadi. Shuningdek, antifungal preparatlarning asosiy guruhlari va profilaktika choralari haqida ma’lumot beriladi.

Files

9-13.pdf

Files (257.7 kB)

Name Size
md5:f878e8838710bc8b31f535c0cee87e43
257.7 kB Preview Download

Additional details

References

  • 1. Brown, G.D., Denning, D.W., Gow, N.A.R., Levitz, S.M., Netea, M.G., & White, T.C. (2012). Hidden killers: human fungal infections. Science Translational Medicine, 4(165), 165rv13. https://doi.org/10.1126/scitranslmed.3004404 2. Köhler, J.R., Casadevall, A., & Perfect, J. (2017). The spectrum of fungal infections. Clinical Microbiology Reviews, 30(4), 885–911. 3. Latgé, J.-P. (1999). Aspergillus fumigatus and aspergillosis. Clinical Microbiology Reviews, 12(2), 310-350. 4. Odds, F.C. (1988). Candida and Candidosis. Baillière Tindall. 5. Park, B.J., Wannemuehler, K.A., Marston, B.J., Govender, N., Pappas, P.G., & Chiller, T.M. (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS, 23(4), 525–530. 6. Thomas, C.F. Jr., & Limper, A.H. (2004). Pneumocystis pneumonia. New England Journal of Medicine, 350(24), 2487-2498. 7. Perfect, J.R. (2017). The antifungal pipeline: a reality check. Nature Reviews Drug Discovery, 16(9), 603–616. 8. Pappas, P.G., Lionakis, M.S., Arendrup, M.C., Ostrosky-Zeichner, L., & Kullberg, B.J. (2018). Invasive candidiasis. Nature Reviews Disease Primers, 4, 18026. 9. Denning, D.W., & Bromley, M.J. (2015). Infectious Disease. How to bolster the antifungal pipeline. Science, 347(6229), 1414–1416. 10. Calderone, R.A., & Clancy, C.J. (Eds.). (2012). Candida and Candidiasis. ASM Press. 11. Kullberg, B.J., & Arendrup, M.C. (2015). Invasive Candidiasis. New England Journal of Medicine, 373(15), 1445–1456. 12. Rajasingham, R., Smith, R.M., Park, B.J., Jarvis, J.N., Govender, N.P., Chiller, T.M., & Boulware, D.R. (2017). Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. The Lancet Infectious Diseases, 17(8), 873–881. 13. Maertens, J.A., & Marr, K.A. (2007). Diagnosis of invasive aspergillosis. Critical Care Clinics, 23(3), 403–442. 14. Walsh, T.J., & Anaissie, E.J. (2012). Clinical Mycology. Elsevier Health Sciences. 15. Richardson, M., & Lass-Flörl, C. (2008). Changing epidemiology of systemic fungal infections. Clinical Microbiology and Infection, 14, 5–24.